Molecular basis of hippocampal energy metabolism in diabetic rats: The effects of SOD mimic

Brain Research Bulletin

Volumn 99, Issue , 2013, Pages 27-33

  Stančić, Ana ^a   Otašević, Vesna ^a   Janković, Aleksandra ^a   Vučetić, Milica ^a   Ivanović Burmazović, Ivana ^b   Filipović, Miloš R ^b   Korać, Aleksandra ^a   Markelić, Milica ^a   Veličković, Ksenija ^a   Golić, Igor ^a   Buzadžić, Biljana ^a   Korać, Bato ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Diabetes; Glycolysis; Hippocampus; Oxidative phosphorylation; SOD mimic

Indexed keywords

ALLOXAN; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MANGANESE DERIVATIVE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRESS; UPREGULATION;

DIABETES; GLYCOLYSIS; HIPPOCAMPUS; OXIDATIVE PHOSPHORYLATION; SOD MIMIC;

ALLOXAN; ANIMALS; CYCLIC GMP; CYTOCHROMES C; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX III; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPOXIA-INDUCIBLE FACTOR 1; KETONE OXIDOREDUCTASES; MALE; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; NITRIC OXIDE SYNTHASE TYPE I; RATS; SUCCINATE-COA LIGASES; SUPEROXIDE DISMUTASE;

EID: 84886067343     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.09.009     Document Type: Article

References (81)

1. Abe T., Takahashi S., Suzuki N. Oxidative metabolism in cultured rat astroglia: effects of reducing the glucose concentration in the culture medium and of d-aspartate or potassium stimulation. J. Cereb. Blood Flow Metab. 2006, 26:153-160.
2. Almeida A., Almeida J., Bolanos J.P., Moncada S. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyteprotection. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15294-15299.
3. Ball K.K., Harik L., Gandhi G.K., Cruz N.F., Dienel G.A. Reduced gap junctional communication among astrocytes in experimental diabetes: contributions of altered connexin protein levels and oxidative-nitrosative modifications. J. Neurosci. Res. 2011, 89:2052-2067.
4. Baydas G., Nedzvetskii V.S., Kirichenko S.V., Nerush P.A. Astrogliosis in the hippocampus and cortex and cognitive deficits in rats with streptozotocin-induced diabetes: effects of melatonin. J. Pineal Res. 2008, 40:105-111.
5. Biessels G.J. Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms. Neth. J. Med. 1999, 54:35-45.
6. Biessels G.J., Kappelle A.C., Bravenboer B., Erkelens D.W., Gispen W.H. Cerebral function in diabetes mellitus. Diabetologia 1994, 37:643-650.
7. Biessels G.J., Braun K.P., de Graaf R.A., van Eijsden P., Gispen W.H., Nicolay K. Cerebral metabolism in streptozotocin-diabetic rats: an in vivo magnetic resonance spectroscopy study. Diabetologia 2001, 44:346-353.
8. Bitar M.S., Koulu M., Rapoport S.I., Linnoila M. Diabetes-induced alteration in brain monoamine metabolism in rats. J. Pharmacol. Exp. Ther. 1986, 236:432-437.
9. Blough N.V., Zafiriou O.C. Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution. Inorg. Chem. 1985, 24:3502-3504.
10. Bolanos J.P., Almeida A., Moncada S. Glycolysis: a bioenergetic or a survival pathway?. Trends Biochem. Sci. 2009, 35:145-149.
11. Brahimi-Horn M.C., Bellot G., Pouysségur J. Hypoxia and energetic tumour metabolism. Curr. Opin. Genet. Dev. 2011, 21:67-72.
12. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
13. Cakatay U., Telci A., Kayali R., Sivas A., Akçay T. Effect of alpha-lipoic acid supplementation on oxidative protein damage in the streptozotocin-diabetic rat. Res. Exp. Med. (Berl.) 2000, 199:243-251.
14. Cameron N.E., Cotter M.A. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J. Clin. Invest. 1995, 96:1159-1163.
15. Cameron N.E., Cotter M.A., Maxfield E.K. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 1993, 36:299-304.
16. Clarke D.D., Sokoloff L. Circulation and energy metabolism of the brain. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects 1999, 637-669. Lippincott-Raven, Philadelphia. 6th ed. G. Siegel, B. Agranoff, R.W. Albers, S. Fisher (Eds.).
17. Coppey L.J., Gellett J.S., Davidson E.P., Dunlap J.A., Lund D.D., Salvemini D., Yorek M.A. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Br. J. Pharmacol. 2001, 134:21-29.
18. Daneman D. Type 1 diabetes. Lancet 2006, 367:847-858.
19. Dees A., Zahl A., Puchta R., Hommes N.J., Heinemann F.W., Ivanović-Burmazović I. Water exchange on seven-coordinate Mn(II) complexes with macrocyclic pentadentate ligands: insight in the mechanism of Mn(II) SOD mimetics. Inorg. Chem. 2007, 46:2459-2470.
20. Dienel G.A., Hertz L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia 2005, 50:362-388.
21. Duarte J.M., Carvalho R.A., Cunha R.A., Gruetter R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J. Neurochem. 2009, 111:368-379.
22. Duckrow R.B., Beard D.C., Brennan R.W. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 1987, 18:52-58.
23. Duelli R., Maurer M.H., Staudt R., Heiland S., Duembgen L., Kuschinsky W. Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res. 2000, 858:338-347.
24. Fanelli C.G., Dence C.S., Markham J., Videen T.O., Paramore D.S., Cryer P.E., Powers W.J. Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes 1998, 47:1444-1450.
25. Feelisch M., Stamler J.S. Preparation and detection of S-nitrosothiols. Methods in Nitric Oxide Research 1996, 521-539. John Wiley & Sons, West Sussex, UK. M. Feelisch, J.S. Stamler (Eds.).
26. Ferreira I.L., Resende R., Ferreiro E., Rego A.C., Pereira C.F. Multiple defects in energy metabolism in Alzheimer's disease. Curr. Drug Targets 2010, 11:1193-1206. [My paper].
27. Filipović M.R., Duerr K., Mojović M., Simeunović V., Zimmermann R., Niketić V., Ivanović-Burmazović I. NO dismutase activity of seven-coordinate manganese(II) pentaazamacrocyclic complexes. Angew. Chem. Int. Ed. Engl. 2008, 47:8735-8739.
28. Filipović M.R., Koh A.C.W., Arbautlt S., Niketic V., Debus A., Schleicher U., Bogdan C., Guille M., Lemaître F., Amatore C., Ivanović-Burmazović I. Striking inflammation from both sides: manganese(II) pentaazamacrocyclic SOD mimics act also as nitric oxide dismutases: a single-cell study. Angew. Chem. Int. Ed. Engl. 2010, 49:4228-4232.
29. Franceschi M., Cecchetto R., Minicucci F., Smizne S., Baio G., Canal N. Cognitive processes in insulin-dependent diabetes. Diabetes Care 1984, 7:228-231.
30. Gandhi G.K., Ball K.K., Cruz N.F., Dienel G.A. Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro. 2010, 2(2):e00030.
31. García-Nogales P., Almeida A., Bolaños J.P. Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection. J. Biol. Chem. 2003, 278:864-874.
32. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 2000, 23:542-549.
33. Grillo C.A., Piroli G.G., Wood G.E., Reznikov L.R., McEwen B.S., Reagan L.P. Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 2005, 136:477-486.
34. Hamprecht B., Verleysdonk S., Wiesinger H. Enzymes of Carbohydrate and Energy Metabolism 2005, 20-215. Oxford University Press, Oxford. 2nd ed. H. Neuroglia, B.R. Kettenmann, Ransom (Eds.).
35. Hertz L., Peng L., Dienel G.A. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood Flow Metab. 2007, 27:219-249.
36. Hounsom L., Corder R., Patel J., Tomlinson D.R. Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia 2001, 44:424-428.
37. Iranzo O. Manganese complexes displaying superoxide dismutase activity: a balance between different factors. Bioorg. Chem. 2011, 39:73-87.
38. Kamal A., Biessels G.J., Urban I.J., Gispen W.H. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience 1999, 90:737-745.
39. Kamal A., Biessels G.J., Ramakers G.M., Hendrik Gispen W. The effect of short duration streptozotocin-induced diabetes mellitus on the late phase and threshold of long-term potentiation induction in the rat. Brain Res. 2005, 1053:126-130.
40. Keegan A., Cotter M.A., Cameron N.E. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia 1999, 42:343-350.
41. Lacković Z., Salković M. Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction. Life Sci. 1990, 46:49-54.
42. Lanier W.L., Hofer R.E., Gallagher W.J. Metabolism of glucose, glycogen, and high-energy phosphates during transient forebrain ischemia in diabetic rats: effect of insulin treatment. Anesthesiology 1996, 84:917-925.
43. Lass P., Knudsen G.M., Pedersen E.V., Barry D.I. Impaired beta-adrenergic mediated cerebral blood flow response in streptozotocin diabetic rats. Pharmacol. Toxicol. 1989, 65:318-320.
44. Lebed Y.V., Orlovsky M.A., Lushnikova I.V., Skibo G.G. Neurodegenerative changes in the hippocampus within the early period of experimental diabetes mellitus. Neurophysiology 2008, 40:26-33.
45. Li Z.G., Zhang W., Grunberger G., Sima A.A. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. 2002, 946:221-231.
46. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997, 46:S38-S42.
47. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
48. Magariños A.M., McEwen B.S. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11056-11061.
49. Mans A.M., DeJoseph M.R., Davis D.W., Hawkins R.A. Brain energy metabolism in streptozotocin-diabetes. Biochem. J 1988, 249:57-62.
50. Manschot S.M., Biessels G.J., Cameron N.E., Cotter M.A., Kamal A., Kappelle L.J., Gispen W.H. Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats. Brain Res. 2003, 966:274-282.
51. Masini E., Cuzzocrea E., Mazzon E., Marzocca C., Mannaioni P.F., Salvemini D. Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo. Br. J. Pharmacol. 2002, 136:905-917.
52. McCall A.L. The impact of diabetes on the CNS. Diabetes 1992, 41:557-570.
53. McCall A.L., Millington W.R., Wurtman R.J. Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:5406-5410.
54. McCuskey P.A., McCuskey R.S. In vivo and electron microscopic study of the development of cerebral diabetic microangiography. Microcirc. Endothelium Lymphatics 1984, 1:221-244.
55. Moreira P.I., Sancha M.S., Rego A.C., Moreno A., Oliveira C. Effect of amyloid β-peptide on the permeability transition pore: a comparative study. J. Neurosci. Res. 2002, 69:257-267.
56. Mukai N., Hori S., Pomeroy M. Cerebral lesions in rats with streptozotocin-induced diabetes. Acta Neuropathol. (Berl.) 1980, 51:79-84.
57. Muscoli C., Cuzzocrea S., Riley D.P., Zweier J.L., Thiemermann C., Wang Z.Q., Salvemini D. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br. J. Pharmacol. 2003, 140:445-460.
58. Obrosova I.G., Fathallah L., Greene D.A. Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of dl-alpha-lipoic acid. Eur. J. Pharmacol. 2000, 398:139-146.
59. Otasevic V., Korac A., Vucetic M., Macanovic B., Garalejic E., Ivanovic-Burmazovic I., Filipovic M.R., Buzadzic B., Stancic A., Jankovic A., et al. Is manganese(II) pentaazamacrocyclic superoxide dismutase mimic beneficial for human sperm mitochondria function and motility?. Antioxid. Redox Signal. 2013, 18:170-178.
60. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999, 53:1937-1942.
61. Pieper G.M., Siebeneich W. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endoth1elial dysfunction. J. Cardiovasc. Pharmacol. 1998, 32:101-105.
62. Piotrowski P., Gajkowska B., Olszewska H., Smialek M. Electron microscopy studies on experimental diabetes and cerebral ischemia in the rat brain. Folia Neuropathol. 1999, 37:256-263.
63. Revsin Y., Saravia F., Roig P., Lima A., de Kloet E.R., Homo-Delarche F., De Nicola A.F. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res. 2005, 1038:22-31.
64. Riley D.P., Schall O.F. Structure-activity studies and the design of synthetic superoxide dismutase (SOD) mimetics as therapeutics. Adv. Inorg. Chem. 2007, 59:233-263.
65. Ryan C.M., Williams T.M. Effects of insulin-dependent diabetes on learning and memory efficiency in adults. J. Clin. Exp. Neuropsychol. 1993, 15:685-700.
66. Salvemini, D., PCT Int. Appl. WO 98/58636, 1998.
67. Sandrini M., Vitale G., Vergoni A.V., Ottani A., Bertolini A. Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain. Life Sci. 1997, 60:1393-1397.
68. Schoenle E.J., Schoenle D., Molinari L., Largo R.H. Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 2002, 45:108-114.
69. Shimizu H. Alteration in hypothalamic monoamine metabolism of freely moving diabetic rat. Neurosci. Lett. 1991, 131:225-227.
70. Simpson I.A., Appel N.M., Hokari M., Oki J., Holman G.D., Maher F., Koehler-Stec E.M., Vannucci S.J., Smith Q.R. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J. Neurochem. 1999, 72:238-247.
71. Takada Y., Noguchi T., Okabe T., Kajiyama M. Superoxide dismutase in various tissues from rabbits bearing the Vx-2 carcinoma in the maxillary sinus. Cancer Res. 1982, 42:4233-4235.
72. Takahashi S., Izawa Y., Suzuki N. Astroglial pentose phosphate pathway rates in response to high-glucose environments. ASN Neuro 2012, 4(2):e00078.
73. Thorré K., Chaouloff F., Sarre S., Meeusen R., Ebinger G., Michotte Y. Differential effects of restraint stress on hippocampal 5-HT metabolism and extracellular levels of 5-HT in streptozotocin-diabetic rats. Brain Res. 1997, 772:209-216.
74. Tkac I., Troscak M., Javorsky M., Petrík R., Tomcová M. Increased intracranial arterial resistance in patients with type 2 diabetes mellitus. Wien. Klin. Wochenschr. 2001, 113:870-873.
75. Vasilijević A., Buzadžić B., Korać A., Petrović V., Janković A., Korać B. Beneficial effects of l-arginine nitric oxide-producing pathway in rats treated with alloxan. J. Physiol. 2007, 584:921-933.
76. Vincent A.M., Russell J.W., Low P., Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 2004, 25:612-628.
77. Vučetić M., Otašević V., Korać A., Stančić A., Janković A., Markelić M., Golić I., Veličković K., Buzadžić B., Korać B. Interscapular brown adipose tissue metabolic reprogramming during cold acclimation: Interplay of HIF-1α and AMPKα. Biochim. Biophys. Acta 2011, 1810:1252-1261.
78. Wagner S.R., Lanier W.L. Metabolism of glucose, glycogen, and high-energy phosphates during complete cerebral ischemia. A comparison of normoglycemic, chronically hyperglycemic diabetic, and acutely hyperglycemic nondiabetic rats. Anesthesiology 1994, 81:1516-1526.
79. Zhang R., Wang L., Zhang L., Chen J., Zhu Z., Zhang Z., Chopp M. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ. Res. 2003, 92:308-313.
80. Zhang W.J., Tan Y.F., Yue J.T., Vranic M., Wojtowicz J.M. Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats. Acta Neurol. Scand. 2008, 117:205-210.
81. Zhu D.Y., Liu S.H., Sun H.S., Lu Y.M. Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. J. Neurosci. 2003, 23:223-229.